Table 1.
First Author (Ref. #) | Year | Age (yrs), Sex | Day of Occurrence∗ | Ejection Fraction, % | Wall Motion Abnormalities | Treatment | Changes on Electrocardiography |
---|---|---|---|---|---|---|---|
Choi et al. (2) | 2011 | 39, female | 18 | 38 | Basal and midanterior | Dexamethasone and diuretic | No change |
Ben El Makki et al. (3) | 2019 | 27, male | 10 | 33 | Diffuse | Vasopressors, diuretic, ACE inhibitor, beta blocker |
Diffuse ST-segment elevation |
Klein et al. (4) | 2007 | 34, female | 19 | No data | No data | No specific treatment | Diffuse ST-segment elevation |
Klein et al. (4) | 2007 | 46, male | 23 | No data | Diffuse | No specific treatment | Diffuse ST-segment elevation |
Fabbiano et al. (5) | 2005 | 45, male | 23 | No data | Posterolateral | No specific treatment | Lateral ST-segment elevation V1 to V2 ST-segment depression |
Van Rijssel et al. (6) | 2010 | 58, male | 21 | No data | No data | The patient died 2 days later | No data |
Carcelero et al. (7) | 2018 | 35, male | 16 | 35 | Diffuse | Anti-inflammatory agents, diuretics, ACE inhibitor, and dobutamine | Diffuse ST-segment elevation |
Isik et al. (8) | 2010 | 9, female | Within first week | 40 | Diffuse | Prednisolone, inotropics, and diuretics | Diffuse voltage depression |
ACE = angiotensin-converting enzyme.
Day of occurrence indicates how many days the event occurred after induction therapy.